Original language | English |
---|---|
Pages (from-to) | 14–16 |
Number of pages | 3 |
Journal | Nature Medicine |
Volume | 30 |
DOIs | |
Publication status | Published - 19 Dec 2023 |
Bibliographical note
Funding Information:Grant funding for OCCAMS infrastructure was provided by Cancer Research UK. Project specific funding for commercial assay technologies applied to OCCAMS samples was provided by Roche and Natera. R.F. is a shareholder in Cyted Ltd, an early diagnosis company.
ASJC Scopus subject areas
- General Biochemistry,Genetics and Molecular Biology